App

The wealth gap among millennials is widening, with the top 10% of the generation accumulating more wealth than their predecessors. While the majority of millennials face challenges such as student debt, low-wage jobs, and unaffordable housing, a small elite group is thriving. According to a recent study, the average millennial has 30% less wealth at
0 Comments
The recent approval by the Food and Drug Administration of Pfizer’s gene therapy for a rare genetic bleeding disorder marks a significant milestone for the company. This approval paves the way for Pfizer to enter the gene therapy market in the U.S., offering a one-time treatment for adults with moderate to severe hemophilia B. Let’s
0 Comments
Alphabet recently released its first-quarter report, exceeding Wall Street’s expectations in terms of sales, operating margin, and profits. Total revenue for the quarter reached $80.54 billion, marking a 15.4% increase year over year. Similarly, earnings per share saw a significant surge of 62% annually, settling at $1.89. This outstanding performance has positioned Alphabet as a
0 Comments
BlackRock, the biggest asset manager in the world, has recently introduced a groundbreaking product called LifePath Paycheck. This innovative product is designed to assist workers in transitioning their retirement savings into a consistent income stream that mirrors the paychecks they received during their working years. The CEO of BlackRock, Larry Fink, described this product as
0 Comments
Synthesia, a Nvidia-backed artificial intelligence firm, has introduced a groundbreaking technology that is set to revolutionize the video production industry. The company’s latest innovation, known as “Expressive Avatars,” enables users to create digital avatars that can convey human emotions simply by inputting text. This advancement in AI technology blurs the lines between the virtual world
0 Comments
Walgreens recently announced a significant expansion of its specialty pharmacy services by partnering directly with drugmakers to make cell and gene therapies more accessible to U.S. patients. This move comes as the company continues to invest in the growing specialty pharmacy segment, highlighting the increasing importance of providing care for patients with chronic, rare, or
0 Comments